GENEVA, Feb. 18 -- TEON THERAPEUTICS, INC. (555 Twin Dolphin Dr., Suite 120Redwood City, California 94065) filed a patent application (PCT/US2025/040925) for "FORMULATIONS OF ADENOSINE RECEPTOR ANTAGONIST" on Aug 06, 2025. With publication no. WO/2026/035860, the details related to the patent application was published on Feb 12, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KARABORNI, Sami (c/o Teon Therapeutics, Inc.555 Twin Dolphin Dr., Suite 120Redwood City, California 94065)
Abstract: Provided here are pharmaceutical formulations containing A2B adenosine receptor antagonists and one o...